To compensate for late shipments, Art's-Way offered dealers last year's prices, contributing to a 0.9% drop in sales and an 88% dip in first-quarter 2009 profits. Since then Majeski has hired a manufacturing manager, hoping to smooth processes going forward.
Art's-Way didn't make the 2009 FSB 100. But Joseph Dancy, manager of LSGI Technology Venture Fund in Dallas, which has a 5% interest in Art's-Way, says it's still his top buy, recently trading at $5.30 per share. Art's-Way has seen a major uptick in queries from government agencies, thanks to federal stimulus funds allocated for scientific projects. Notes Dancy: "Labs will be in huge demand."
- Why 3% is the scariest number for stocks
- GE warns restated results will shrink 2016 and 2017 profits
- Supreme Court to hear high-stakes Microsoft case testing email privacy
- How Buffett beat the hedge funds
- As DACA debate continues, these Dreamers are saving lives
- Bank of America wants to talk to its customers who make guns